NARG2 抗体 (AA 201-300) (PE)
Quick Overview for NARG2 抗体 (AA 201-300) (PE) (ABIN6988863)
抗原
适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 201-300
-
交叉反应
- 人, 小鼠, 大鼠
-
预测反应
- Dog
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human NARG2
-
亚型
- IgG
-
-
-
-
应用备注
- FCM 1:20-100
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
有效期
- 12 months
-
-
- NARG2 (NMDA Receptor Regulated 2 (NARG2))
-
别名
- NARG2
-
背景
-
Synonyms: BRCC1, NARG2, Little elongation complex subunit 2, Interactor of little elongator complex ELL subunit 2, NMDA receptor-regulated protein 2, ICE2, UNQ3101/PRO10100
Background: Component of the little elongation complex (LEC), a complex required to regulate small nuclear RNA (snRNA) gene transcription by RNA polymerase II and III.
-
基因ID
- 79664
-
UniProt
- Q659A1
抗原
-